Matthew E Korenberg - Net Worth and Insider Trading
Matthew E Korenberg Net Worth
The estimated net worth of Matthew E Korenberg is at least $7 Million dollars as of 2024-06-04. Matthew E Korenberg is the President & Chief Operating of Ligand Pharmaceuticals Inc and owns about 86,263 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $7 Million. Details can be seen in Matthew E Korenberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew E Korenberg has not made any transactions after 2024-05-14 and currently still holds the listed stock(s).
Transaction Summary of Matthew E Korenberg
Matthew E Korenberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew E Korenberg owns 3 companies in total, including Ligand Pharmaceuticals Inc (LGND) , Ritter Pharmaceuticals Inc (RTTR) , and Qualigen Therapeutics Inc (QLGN) .
Click here to see the complete history of Matthew E Korenberg’s form 4 insider trades.
Insider Ownership Summary of Matthew E Korenberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-05-14 | VP & Finance and CFO |
| RTTR | Ritter Pharmaceuticals Inc | 2020-06-06 | director |
| QLGN | Qualigen Therapeutics Inc | 2020-05-22 | director |
Matthew E Korenberg Latest Holdings Summary
Matthew E Korenberg currently owns a total of 1 stock. Matthew E Korenberg owns 86,263 shares of Ligand Pharmaceuticals Inc (LGND) as of May 14, 2024, with a value of $7 Million.
Latest Holdings of Matthew E Korenberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-05-14 | 86,263 | 80.83 | 6,972,638 |
Holding Weightings of Matthew E Korenberg
Matthew E Korenberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew E Korenberg has made a total of 2 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 17,598 shares on May 14, 2024, which brought Matthew E Korenberg around $1 Million.
Insider Trading History of Matthew E Korenberg
- 1
Matthew E Korenberg Trading Performance
GuruFocus tracks the stock performance after each of Matthew E Korenberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew E Korenberg is 27.35%. GuruFocus also compares Matthew E Korenberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew E Korenberg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew E Korenberg's insider trading performs compared to the benchmark.
Performance of Matthew E Korenberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.81 | | | | | |
| Relative Return to S&P 500(%) | 16.66 | | | | | |
Matthew E Korenberg Ownership Network
Matthew E Korenberg Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Matthew E Korenberg is the VP & Finance and CFO of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , CHIEF LEGAL OFFICER & Andrew Reardon , and CEO & President John L Higgins .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Matthew E Korenberg made 1 insider transaction in Ligand Pharmaceuticals Inc (LGND) with a net sale of 17,598. Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 13,433 shares made by Octavio Espinoza , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 10,300 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 43,718 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 43,718 shares. During the past 18 months, 71,418 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 67,418 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Matthew E Korenberg Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew E Korenberg. You might contact Matthew E Korenberg via mailing address: 11119 North Torrey Pines Road, Suite 200, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
